Search research articles
Contact Us
Filters
Showing results (191-200 of 199) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 199 results.
Blood
|
September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus
C B Foster, T Lehrnbecher, S Samuels, et al.
Experimental Eye Research
|
July 29, 2015
Loss of DJ-1 elicits retinal abnormalities, visual dysfunction, and increased oxidative stress in mice
Vera L Bonilha, Brent A Bell, Mary E Rayborn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 24, 2021
Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy
Nicholas C Holoman, Jacob J Aiello, Timothy D Trobenter, et al.
International Journal of Geriatric Psychiatry
|
August 19, 2014
Integration of geriatric mental health screening into a primary care practice: a patient satisfaction survey
S Samuels, R Abrams, R Shengelia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 29, 2022
Glucose uptake by GLUT1 in photoreceptors is essential for outer segment renewal and rod photoreceptor survival
Lauren L Daniele, John Y S Han, Ivy S Samuels, et al.
Neuron
|
August 13, 2011
Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function
Ryota L Matsuoka, Onanong Chivatakarn, Tudor C Badea, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2019
Efficacy of PD-1 blockade in cervical cancer is related to a CD8<sup>+</sup>FoxP3<sup>+</sup>CD25<sup>+</sup> T-cell subset with operational effector functions despite high immune checkpoint levels
A M Heeren, J Rotman, A G M Stam, et al.
Frontiers in Immunology
|
January 11, 2021
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
Jossie Rotman, Leontine A S den Otter, Maaike C G Bleeker, et al.
Oncoimmunology
|
March 28, 2017
Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
H van Meir, R A Nout, M J P Welters, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 199) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 199 results.
Blood
|
September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus
C B Foster, T Lehrnbecher, S Samuels, et al.
Experimental Eye Research
|
July 29, 2015
Loss of DJ-1 elicits retinal abnormalities, visual dysfunction, and increased oxidative stress in mice
Vera L Bonilha, Brent A Bell, Mary E Rayborn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 24, 2021
Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy
Nicholas C Holoman, Jacob J Aiello, Timothy D Trobenter, et al.
International Journal of Geriatric Psychiatry
|
August 19, 2014
Integration of geriatric mental health screening into a primary care practice: a patient satisfaction survey
S Samuels, R Abrams, R Shengelia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 29, 2022
Glucose uptake by GLUT1 in photoreceptors is essential for outer segment renewal and rod photoreceptor survival
Lauren L Daniele, John Y S Han, Ivy S Samuels, et al.
Neuron
|
August 13, 2011
Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function
Ryota L Matsuoka, Onanong Chivatakarn, Tudor C Badea, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2019
Efficacy of PD-1 blockade in cervical cancer is related to a CD8<sup>+</sup>FoxP3<sup>+</sup>CD25<sup>+</sup> T-cell subset with operational effector functions despite high immune checkpoint levels
A M Heeren, J Rotman, A G M Stam, et al.
Frontiers in Immunology
|
January 11, 2021
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
Jossie Rotman, Leontine A S den Otter, Maaike C G Bleeker, et al.
Oncoimmunology
|
March 28, 2017
Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
H van Meir, R A Nout, M J P Welters, et al.
Page
of 20